News Abortion

‘1 in 3’ Speakout Offers What’s Often Missing in Abortion Debate: Personal Stories [Video]

Rewire Staff

The event is part of a national movement aimed at refocusing the debate on abortion from a political perspective to a personal one.

On Tuesday, January 19, a live-streamed abortion speak-out will feature a diverse group of women who will discuss their personal experiences with abortion and abortion care.

Hosted by the 1 in 3 Campaign, and streaming live on this page beginning at noon Eastern Standard Time, the event is part of a national movement aimed at refocusing the debate on abortion from a political perspective to a personal one.

“The Supreme Court justices need to hear the real effects of restrictive abortion laws on women like this one in Texas,” said Advocates for Youth President Debra Hauser, who shared her story in a statement. “What is missing from this issue are our personal stories. The reality is that one in three women will have an abortion in her lifetime. Rather than making care prohibitively expensive and unduly difficult, we should work to protect safe access to abortion care and make sure women receive the care they need.”

Watch the event here:

Appreciate our work?

Vote now! And help Rewire earn a bigger grant from CREDO:



Analysis Abortion

Attacks on Abortion Rights Continued in 2015, Ensnaring Family Planning Funding and Fetal Tissue Research

Rachel Benson Gold & Elizabeth Nash

The year will be remembered not only because 17 states enacted a total of 57 new abortion restrictions, but also because the politics of abortion ensnared family planning programs, providers, and life-saving fetal tissue research.

During 2015’s state legislative sessions, lawmakers considered 514 provisions related to abortion; the vast majority of these measures—396 in 46 states—sought to restrict access to abortion services. The year will be remembered not only because 17 states enacted a total of 57 new abortion restrictions, but also because the politics of abortion ensnared family planning programs and providers, as well as critical, life-saving fetal tissue research.

2015 may also be memorable for setting the stage for what is widely anticipated to be one of the most significant Supreme Court rulings on abortion since 1992. In November, the Court agreed to hear a challenge to a Texas law requiring abortion providers to adhere to the standards set for ambulatory surgical centers and to have admitting privileges at a local hospital. At stake is the question of how far states may go in regulating abortion before their actions amount to an unconstitutional “undue burden” on women’s ability to access care. The Court will hear the case in March, with a decision expected in June; it is still considering whether to review a Mississippi admitting-privileges law. (Also in 2016, the Court will revisit the contraceptive coverage guarantee under the Affordable Care Act, weighing its importance and approach against the contention of religiously affiliated employers that they deserve to be entirely exempt from the law.)

At the same time, several states made important advances in 2015 on other sexual and reproductive health and rights issues. Some of the new provisions include measures that allow women to obtain a full year’s worth of prescription contraceptives at one time from a pharmacy, that allow a provider to treat a patient’s partner for an STI without first seeing the patient, that prohibit the use of “conversion therapy” with minors, and that expand access to dating or sexual violence education. See our full analysis for details.

Access to Abortion Services

Appreciate our work?

Vote now! And help Rewire earn a bigger grant from CREDO:


Including the 57 abortion restrictions enacted in 2015, states have adopted 288 abortion restrictions just since the 2010 midterm elections swept abortion opponents into power in state capitals across the country. To put that number in context, states adopted nearly as many abortion restrictions during the last five years as they did during the entire previous 15 years. Moreover, the sheer number of new restrictions enacted in 2015 makes it clear that this sustained assault on abortion access shows no signs of abating.


The 288 new restrictions enacted since 2010 include a broad range of approaches, from banning certain types of abortions to putting restrictions on the providers allowed to perform the procedures to limiting insurance coverage.


Thirty-one states—spanning all regions of the country—enacted at least one abortion restriction during the last five years. The ten states that enacted at least ten new restrictions together accounted for 60 percent of the 288 new abortion restrictions adopted over the last five years. These states are overwhelmingly located in the South and the Midwest, and it is likely that access to services for women in these regions has been impacted significantly. Four states—Arkansas, Indiana, Kansas, and Oklahoma—each enacted at least 20 new abortion restrictions, making this handful of states, which together adopted 94 new restrictions, responsible for a third of all abortion restrictions enacted nationwide over the last five years. Kansas has the dubious distinction of leading the pack with 30 new abortion restrictions since 2010.

heat map

Although the 57 new abortion restrictions enacted during 2015 include a wide range of provisions, four topics stood out as the subject of particular attention among lawmakers:

1. Counseling and Waiting Periods

Five states adopted new (Florida and Tennessee) or lengthened existing (Arkansas, North Carolina, and Oklahoma) waiting period legislation in 2015. (The new Florida law has been temporarily blocked by the courts; the Oklahoma law is also being challenged, but a state court allowed it to go into effect while the case is pending.) Including these new laws, 27 states have waiting periods in effect. The new laws in Florida and Tennessee require the pregnant person to receive state-mandated abortion counseling in person, meaning that she must make two separate trips to obtain an abortion. With enforcement of the Florida law blocked, 13 states have two-trip requirements in effect.

2. Medication Abortion

Three states sought to use longstanding strategies to restrict access to medication abortion. Arkansas, Idaho, and Kansas enacted new measures banning the use of telemedicine for the provision of medication abortion. Arkansas also mandated use of the regimen specified in the FDA-approved labeling, which bans the use of the newer evidence-based regimen that is less costly, has fewer side effects, and can be used several days later in pregnancy; the law is not in effect due to a court case. Currently, 18 states ban the use of telemedicine and four require providers to follow an outdated medication abortion regimen.

Arizona and Arkansas debuted a new approach to discourage a woman from obtaining a medication abortion. Both states adopted laws requiring doctors to counsel women that the abortion could be stopped if the woman takes a high dose of progesterone after receiving the first of the two drugs included in the medication abortion regimen. According to the American Congress of Obstetricians and Gynecologists, this new approach is based on scant scientific evidence; it relies on a single flawed study of only six cases that did not have oversight by an institutional review board. The Arizona law is blocked pending a legal challenge; the Arkansas law is in effect.

3. Abortions After the First Trimester

Anti-choice lawmakers unveiled a new strategy in 2015 by moving to ban the use of the procedure used most often for second-trimester abortions. Kansas and Oklahoma both enacted measures to ban this safe and medically proven method that has long been used for abortions after 14 weeks; both laws are enjoined pending court action.

West Virginia and Wisconsin enacted laws banning abortion at or after 20 weeks post-fertilization (which is equivalent to 22 weeks after the woman’s last menstrual period). The West Virginia measure is in effect; the one in Wisconsin is slated to go into effect in February. Currently, 12 states have similar bans in effect.

4. Targeted Regulation of Abortion Providers (TRAP)

Even as the stage was being set for the U.S. Supreme Court to review TRAP laws, as we reviewed above, legislative action continued apace in several states. Five states adopted TRAP laws in 2015. Following a 2014 ballot initiative that granted lawmakers the ability to enact virtually limitless abortion restrictions, Tennessee enacted a new TRAP law that requires abortion providers to meet the standards that apply to ambulatory surgical centers even though these centers typically provide more invasive and risky procedures than abortion and use higher levels of sedation than commonly provided in abortion clinics.

Arkansas, Indiana, Ohio, and Oklahoma made existing requirements more stringent.

Family Planning Providers

In the aftermath of the release of a series of deceptively edited sting videos aimed at Planned Parenthood, attempts to defund the organization have flared at both the federal and state levels. By the end of 2015, some 11 states had moved to slash funding either for Planned Parenthood health centers specifically or for any family planning provider that also offers abortion services. A Guttmacher analysis shows that defunding Planned Parenthood could seriously impair women’s access to needed services: In two-thirds of the 491 counties in which they are located, Planned Parenthood health centers serve at least half of all women obtaining contraceptive care from safety-net health centers. In one-fifth of the counties in which they are located, Planned Parenthood sites are the sole safety-net family planning center.


States have targeted a variety of funding streams on which family planning providers rely to fund the breadth of their services and activities, and are likely to continue in this vein in the upcoming 2016 legislative sessions:


Mirroring events in Congress, five states—Alabama, Arkansas, Louisiana, Oklahoma, and Texas—took steps to exclude Planned Parenthood from the Medicaid program in 2015. These efforts were blocked by federal courts in Alabama, Arkansas, and Louisiana; a challenge was just filed in November in Texas. Similar efforts made by Arizona and Indiana in recent years were also rebuffed by federal courts.

Other Family Planning Funding

Following the release of the videos, North Carolina expanded its existing provision blocking state funding of “non-public” family planning providers to explicitly apply to family planning providers that also offer abortion services. (Similar measures to bar funding for family planning providers that offer abortion care were introduced in Illinois, Pennsylvania, and Wisconsin.) In addition, New Hampshire’s Executive Council, an administrative board charged with overseeing large funding streams in the state, excluded Planned Parenthood health centers from receiving federal Title X dollars that flow through the state. (Title X funding that Planned Parenthood receives directly from the federal government is not affected.)

Currently, ten states limit eligibility for family planning funding. Eight of these states—Arizona, Arkansas, Colorado, Indiana, North Carolina, Ohio, Texas, and Wisconsin—prohibit abortion providers from receiving state family planning dollars. Kansas and Oklahoma exclude family planning providers not operated by public entities from eligibility.

Funding for Related Services and Activities

North Carolina and Utah moved to exclude family planning providers from eligibility for funding for related services. Legislation enacted in North Carolina bars family planning providers that offer abortion services from receiving funding for adolescent parenting and teen pregnancy prevention programs. Utah Gov. Gary Herbert (R) directed the state department of health to discontinue any funding for Planned Parenthood health centers, including funding for STI surveillance efforts, STI testing and treatment, and abstinence education; a federal appellate court recently prohibited the state from excluding Planned Parenthood from the funds.

Fetal Tissue Donation and Research

As yet another consequence of the release of the Planned Parenthood sting videos, ten states moved to regulate either the process for fetal tissue donation or biomedical research conducted in the state using fetal tissue resulting from induced abortions. Fetal tissue research has been integral to many of the major medical advances of our age. For example, fetal cell lines were used in the development of the polio vaccine and vaccines for diseases such as measles, mumps, rubella, chickenpox, hepatitis A, and rabies. In short, fetal tissue research has saved and improved the lives of millions of people worldwide.

During the final months of 2015, North Carolina and Arizona moved to regulate fetal tissue donation and research. A law enacted in North Carolina prohibits the sale of fetal tissue for a profit, paralleling federal requirements. Arizona adopted an emergency regulation requiring facilities to report any donation of fetal tissue to the state. Measures related to fetal tissue donation and research were introduced last year in Alabama, California, Michigan, New Jersey, Ohio, New York, and Wisconsin.

Editor’s note: Gwendolyn Rathbun and Zohra Ansari-Thomas also contributed to this analysis.

Commentary Contraception

Health Care in Our Hands: Celebrating a Decade of Work to Get Emergency Contraception on Store Shelves

Jessica Arons

August 1 is the one-year anniversary of the Affordable Care Act regulation requiring no cost-coverage of women’s preventive services—including contraception—going into effect. Now we can also celebrate the fact that Plan B One-Step is finally on store shelves across the country.

August 1 has become an important day for women’s health. Not only does it mark the one-year anniversary of the Affordable Care Act regulation requiring no-cost coverage of women’s preventive services—including contraception—going into effect, but now we can also celebrate the fact that Plan B One-Step emergency contraception is finally on store shelves across the country and more accessible than ever before.

Reproductive health, rights, and justice advocates work hard every single day to ensure that women and men are equipped with the tools and information they need to plan pregnancies and determine the course of their own lives. But we seldom take the time to celebrate our victories when they do occur—or to acknowledge and learn from the work that makes victories like August 1 possible.

In the case of emergency contraception (EC), advocates, activists, lawyers, lawmakers, researchers, and health-care providers have been working for more than a decade to make safe and effective back-up birth control available to all—without a prescription, age limits, or delays. Here are some of the highlights from that history:

  • 1995 – Reproductive Health Technologies Project (RHTP) board members Felicia Stewart and Charlotte Ellertson champion an “idea” for a product that would prevent pregnancies after intercourse.

    Appreciate our work?

    Vote now! And help Rewire earn a bigger grant from CREDO:


  • 1997 – Sharon Camp, also an RHTP board member at the time, starts the Women’s Capital Corporation, responsible for the development and commercialization of Plan B emergency contraception.

  • 1999 – James Trussell and Marie Bass launch a hotline and a groundbreaking television and radio campaign to educate the public about EC.

  • 2001 – RHTP, the Center for Reproductive Rights (CRR), and groups including the American Academy of Pediatrics and the Association of Reproductive Health Professionals, submit a Citizen’s Petition to the Food and Drug Administration (FDA).

  • 2003 – Two FDA advisory committees overwhelmingly recommend the sale of Plan B over the counter (OTC) without a prescription.

  • 2004 – Despite its experts’ own recommendations, the FDA denies approval of Plan B OTC.

  • 2005 – CRR files a lawsuit, using the Citizen’s Petition and leaked FDA staff review memos.

  • 2005 – After months of internal and external wrangling, Dr. Susan Wood resigns from the FDA in protest of the Bush administration’s disregard for scientific and clinical evidence.

  • 2005 – National Women’s Liberation protests the FDA’s delay in New York City—a tradition that continues into 2013.

  • 2006 – Thanks to the efforts of Sens. Hillary Rodham Clinton and Patty Murray, the Bush administration is forced to concede OTC access for those 18 and older in order to get the next FDA commissioner confirmed.

  • 2009 – Judge Edward Korman finds that politics had trumped science, orders the age restriction on OTC access to be lowered to 17, and demands that the FDA revisit its decision on EC.

  • 2009 – The National Latina Institute for Reproductive Health publishes a primer on birth control and emergency contraception aimed at Latina women, available in English and Spanish.

  • 2009 – Elizabeth Raymond and colleagues publish research demonstrating that people ages 12 to 17 can use EC safely without assistance from a gatekeeper like a physician or pharmacist.

  • 2011 – In an unprecedented move, Department of Health and Human Services Secretary Kathleen Sebelius overrules the FDA’s decision to grant OTC access to Plan B One-Step, and CRR reopens its lawsuit against the FDA.

  • 2012 – Tina Raine and colleagues publish findings showing that young people can use EC safely in an over-the-counter context.

  • 2012 – The American College of Obstetricians and Gynecologists releases a statement calling for the removal of unnecessary restrictions on EC.

  • 2012 – RHTP and other women’s health advocates keep the pressure on with a nationwide social media campaign calling on the Obama Administration to remove restrictions on EC.

  • 2013 – The American College of Clinical Pharmacy issues its support for the elimination of barriers to EC.

  • 2013 – Finally, after Judge Korman kicks up the heat and rules that the FDA must make EC available without restrictions, and the Department of Justice loses an important part of its appeal, we cry “Victory!” as the headlines read, “Feds Cave on EC Age Restrictions.”

Now, because of those efforts and the efforts of so many others, anyone will be able to walk into a pharmacy or grocery store and grab EC from the store shelf. They won’t have to wait or come back when the pharmacy counter is open. They won’t have to be embarrassed to ask for it in front of others or be shamed about needing to use it. They won’t have to show identification or find someone who has identification to buy it for them. Finally, our health care is in our hands.

But while we can claim “victory,” we cannot claim “mission accomplished.” The FDA granted Teva Pharmaceuticals, the maker of Plan B One-Step, three-year market exclusivity for an over-the-counter EC product for all ages—which means that until April 2016, all generic versions of EC will continue to have cumbersome and unnecessary age restrictions. Additionally, the average price of generic EC is $41, only $7 less than the average cost of $48 for Plan B One-Step. Clearly, there is a lot more work to do.

Even so, on Thursday we celebrate. And we honor the hard work, the vision, the creativity, and the perseverance of those who put EC in women’s hands. To them we say, thank you.


To help us celebrate, please share photos and videos of EC in your hands. Learn more at


Vote for Rewire and Help Us Earn Money

Rewire is in the running for a CREDO Mobile grant. More votes for Rewire means more CREDO grant money to support our work. Please take a few seconds to help us out!


Thank you for supporting our work!